Tilray secures approval regarding US clinical trial, share price soars

By baddey dey`
Canadian cannabis producer Tilray Inc has received approval from the US Drug Enforcement Agency (DEA) to import a cannabis product to the US for a clinical trial at the University of California, San Diego
 
The news has seemingly prompted another spike in the company’s share price, improving by 30% on 18 September and pushing their value to an increase of over 800% since the IPO launch.
 
Financial Post said that this has boosted the company’s market valuation to “about US$14.4 billion”, placing it well above previous leader Canopy Growth Corp at “around US$11.5 billion”.
 
According to CNBC, the clinical trial in San Diego will “study the safety, tolerability and efficacy of marijuana for a neurological disorder”.
 
Tilray CEO Brendan Kennedy said of the trial’s impact on the company’s prospects:
 
“Clinical trials build a halo around the brand”.
 
See more:
 
 
“They inspire confidence and trust with physicians and regulators around the world and they give us data and information to talk to pharmacists and physicians that they just can’t obtain from our competitors”.
 
Canada’s fast-approaching legalization of recreational cannabis use has thus far seen stocks across the industry jump in value, though Tilray’s market growth is particularly remarkable.
 
Companies including Coca-Cola are keen to cash-in on the emerging market, with the soft drink company reportedly interested in producing cannabis-infused products.
Share

Featured Articles

UAE building cybersecurity fortress for a safer world

Exclusive: His Excellency Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government, on bold plans to build the world’s most secure digital society

The future of cybersecurity must be built on the basics

HE Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government and Dr Aloysius Cheang, Chief Security Officer Huawei UAE, on the future of cybersecurity

10 of the best speakers at Procurement & Supply Chain LIVE

Global industry leaders, many from US, descended on London for a two-day conference dedicated to shaping the future of digital procurement and supply chain

10 apps to support staff on World Mental Health Day

Leadership & Strategy

DEI done right: Brook Sims, COO, MAC Diversity Recruiters

Leadership & Strategy

Q&A: China’s ecommerce innovator Jeff Li, CEO of Shoplazza

Leadership & Strategy